Beltway Insights: What’s Happening in DC from COVID-19 Developments to Prospects for IP Legislation

In this CLE program, we will demystify the intricacies of AI patenting and set a clear path to success. Our esteemed speakers, possessing extensive experience in AI patent law, will provide practical insights and actionable advice that will reshape your approach to patenting AI innovations.

Join us for this interactive roundtable discussing trends and predictions for privacy law in 2021. Will federal privacy legislation finally gain momentum? Will Washington State pass its comprehensive privacy law? How have companies’ CCPA compliance processes changed and how will they continue to evolve in light of enforcement and litigation activity? In addition to legislative updates, we can discuss how companies are adapting to industry-led privacy developments and requirements such as Apple’s iOS 14, browser blocking of third-party cookies, and industry CCPA/advertising opt-out solutions. We look forward to sharing our thoughts and hearing yours as discuss the current state of play regarding these issues others for 2021.

In today's fast-paced and competitive business landscape, protecting a company’s intellectual property is critical to the success of the business and the responsibility lies with in-house counsel to ensure that the company takes the right steps to protect and create these assets. As disputes and litigation surrounding IP rights are becoming increasingly common, failing to have the right agreements, policies, training, and plans in place can be detrimental to an organization. Fortunately, there are a number of things you can do as General Counsel to help the company protect its intellectual property. In this dynamic session, our expert panelists will explore how to successfully navigate this complex terrain and the essential components of building a robust and versatile toolkit that equips your legal department with the knowledge and strategies necessary for effective IP litigation.

This panel will discuss various issues and challenges accompanying sales of health care assets, including factors to consider in determining whether or not a sale is the best alternative. Such factors include the role of regulatory authorities, political challenges, reimbursement issues, issues related to urban vs. rural facilities, the evolution of the health care business, and best practices in navigating such challenges.